Publications
2013
Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors.
Montano EN,
Boullier A,
Almazan F,
Binder CJ,
Witztum JL,
Hartvigsen K.
J Lipid Res. 2013 Nov;54(11):3206-3214.
2013
Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
Lichtman AH,
Binder CJ,
Tsimikas S,
Witztum JL.
J Clin Invest. 2013 Jan 2;123(1):27-36.
2013
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC,
de Jager SC,
Ewing MM,
de Vries MR,
Bot I,
van Santbrink PJ,
Redeker A,
Mallat Z,
Binder CJ,
Arens R,
Jukema JW,
Kuiper J,
Quax PH.
Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2810-7. doi: 10.1161/ATVBAHA.113.301882. Epub 2013 Oct 10.
2013
Macrophage Specific Caspase-1/11 Deficiency Protects against Cholesterol Crystallization and Hepatic Inflammation in Hyperlipidemic Mice.
Hendrikx T,
Bieghs V,
Walenbergh SM,
van Gorp PJ,
Verheyen F,
Jeurissen ML,
Steinbusch MM,
Vaes N,
Binder CJ,
Koek GH,
Stienstra R,
Netea MG,
Hofker MH,
Shiri-Sverdlov R.
PLoS One. 2013 Dec 2;8(12):e78792. doi: 10.1371/journal.pone.0078792.
2013
Disease-specific molecular events in cortical multiple sclerosis lesions.
Fischer MT,
Wimmer I,
Höftberger R,
Gerlach S,
Haider L,
Zrzavy T,
Hametner S,
Mahad D,
Binder CJ,
Krumbholz M,
Bauer J,
Bradl M,
Lassmann H.
Brain. 2013 June; 136(6): 1799–1815.
2013
Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation.
Bieghs V,
Walenbergh SM,
Hendrikx T,
van Gorp PJ,
Verheyen F,
Olde Damink SW,
Masclee AA,
Koek GH,
Hofker MH,
Binder CJ,
Shiri-Sverdlov R.
Liver Int. 2013 Aug;33(7):1056-61.
2012
Natural Antibodies and Atherosclerosis; pp.
Tsiantoulas D,
Binder CJ.
289-304 in Inflammation and Atherosclerosis; Springer; Edited by Georg Wick & Cecilia Grundtman.
2007
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.
Hartvigsen K,
Binder CJ,
Hansen LF,
Rafia A,
Juliano J,
et al.
Arterioscl Thromb Vasc Biol. 2007, 27(4):878–85.
2007
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice.
Bro S,
Binder CJ,
Witztum JL,
Olgaard K,
Nielsen LB.
Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6.
2007
Promise of immune modulation to inhibit atherogenesis.
Binder CJ,
Hartvigsen K,
Witztum JL.
J Am Coll Cardiol. 2007, 50(6):547–50.
